Direct from NHS and industry speakers, pharma market access professionals will gain inside insight into the changing NHS environment and what this means for market access, at our upcoming seminar.
The seminar will feature key addresses from speakers who work in and with the NHS and who understand the changing healthcare landscape. Our speakers will provide valued and actionable insights into how these changes will impact pharma market access relationships with decision makers in both primary and secondary care.
The seminar will be held on 25th September at the Royal College of Physicians.
What will attendees explore?
With Payment by Results use declining and commissioning bodies becoming more complex, a new, reformed NHS is emerging with new reimbursement challenges.
At this seminar, attendees will delve into the detail of what concerns them as pharma professionals when planning market access activities, in light of the current and future structural and functional changes to the NHS.
The seminar will include the following sessions, followed by an ‘Ask the Speakers’ question and answer session:
- ‘Be Careful What You Wish For – Opportunity and Challenge from the New NHS’ from David Thorne, Chair, Washington Community Health Care; Non-Executive Director, City and Vale GP Alliance (York) and Director of NHS Insights and Interaction, Mtech Access.
- ‘Transforming Secondary Care: Challenges and Opportunities’ from Mike Proctor, Chief Executive of York Teaching Hospitals NHS Foundation Trust
- ‘The Role of Primary Care Networks & their impact on Pharma’ from Emma Clayton, Senior Executive Director, Grey Bear Consultancy
- ‘Engaging with Impact: Market Access and the new NHS’ from James Roach, Director, West Essex Integrated Care Partnership
“If you’re in pharma market access, this seminar is for you. With Mike, Emma, James and David all sharing their perspectives, we have the chance to explore the different challenges affecting different areas of the NHS and what this means for market access. I firmly believe the seminar will offer pharma market access professionals unique insights that they can take away and action to drive positive change.” – David Niziol, MD, Mtech Access.
David Thorne, newly appointed Director of NHS Insights and Interaction at Mtech Access, will open the seminar by sharing his perspectives on the opportunities and challenges arising from recent changes in the NHS and what this means for market access professionals as they look to engage with and support NHS customers.
David will draw on his extensive experience leading transformations in the NHS, both from his current roles as Chair of Washington Community Health Care and Non-Executive Director at City and Vale GP Alliance (York), as well as from his past experience as Chief Executive of Newcastle West CCG.
“I’m really looking forward to contributing to this seminar, alongside Mike, Emma and James. This is a great opportunity to explore and answer some of the questions that are perplexing all of us regarding NHS change, and how these will impact pharma market access.” – David Thorne, Director of NHS Insights & Interaction, Mtech Access.